Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Danaher Corp DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the... see more

Recent & Breaking News (NYSE:DHR)

Danaher To Present At Cowen Healthcare Conference

PR Newswire February 22, 2021

Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator

Canada NewsWire February 1, 2021

Danaher Reports Fourth Quarter And Full Year 2020 Results

PR Newswire January 28, 2021

Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs

PR Newswire January 25, 2021

Cepheid Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Combination Test

Canada NewsWire January 14, 2021

Danaher CEO To Comment On Financial Performance

PR Newswire January 13, 2021

Danaher Schedules Fourth Quarter 2020 Earnings Conference Call

PR Newswire January 7, 2021

Danaher To Present At J.P. Morgan Healthcare Conference

PR Newswire January 7, 2021

Danaher Announces Executive Appointment

PR Newswire December 21, 2020

Danaher announces leadership appointment

PR Newswire December 14, 2020

Danaher Announces Quarterly Dividend

PR Newswire December 8, 2020

Danaher To Present At Evercore ISI HealthCONx Conference

PR Newswire November 24, 2020

Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test

PR Newswire November 23, 2020

Danaher To Present At Wolfe Research Healthcare Conference

PR Newswire November 16, 2020

Danaher Releases 2020 Sustainability Report

PR Newswire November 10, 2020

Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs

PR Newswire November 10, 2020

Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements

Canada NewsWire October 27, 2020

Danaher Reports Third Quarter 2020 Results

PR Newswire October 22, 2020

Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children

PR Newswire October 15, 2020

Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization

PR Newswire October 9, 2020